(Go: >> BACK << -|- >> HOME <<)

Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Overview

Feature Articles

Latest Alzheimer's & Dementia News and Research

Study: 13% of older adults diagnosed with traumatic brain injury

Study: 13% of older adults diagnosed with traumatic brain injury

Study examines prescribing patterns of tricyclic antidepressants for treatment of diabetic peripheral neuropathy

Study examines prescribing patterns of tricyclic antidepressants for treatment of diabetic peripheral neuropathy

Study reveals sex-specific cognitive effects of astrocytic receptors

Study reveals sex-specific cognitive effects of astrocytic receptors

Older adults with a criminal background found to have higher risk of developing dementia

Older adults with a criminal background found to have higher risk of developing dementia

Memory decline reported by patients and partners may signal early Alzheimer's changes

Memory decline reported by patients and partners may signal early Alzheimer's changes

Self-reported memory problems and partner confirmation may signal tau buildup in the brain

Self-reported memory problems and partner confirmation may signal tau buildup in the brain

Transparent skull implant unveils new frontiers in brain imaging

Transparent skull implant unveils new frontiers in brain imaging

Online stress management intervention reduces burden for family caregivers of dementia patients

Online stress management intervention reduces burden for family caregivers of dementia patients

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

Research reveals loneliness as a complex interplay of social impairments, oxytocin, and illness

Research reveals loneliness as a complex interplay of social impairments, oxytocin, and illness

New help for dealing with aggression in people with dementia

New help for dealing with aggression in people with dementia

Researchers identify novel way to potentially slow down or halt Alzheimer’s progression

Researchers identify novel way to potentially slow down or halt Alzheimer’s progression

AI could offer companionship to lonely people

AI could offer companionship to lonely people

Phytochemicals show promise in treating neurological disorders by influencing the gut-brain axis

Phytochemicals show promise in treating neurological disorders by influencing the gut-brain axis

Upward socioeconomic mobility reduces dementia risk, study finds

Upward socioeconomic mobility reduces dementia risk, study finds

Comprehensive study provides new understandings of genomic influences on neuropsychiatric disease

Comprehensive study provides new understandings of genomic influences on neuropsychiatric disease

Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals

Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals

Study offers insights into factors influencing older adults to stop driving

Study offers insights into factors influencing older adults to stop driving

Breakthrough study reveals molecular drivers of Alzheimer's progression

Breakthrough study reveals molecular drivers of Alzheimer's progression

AI algorithm maps protein clumping characteristics in neurodegenerative disorders

AI algorithm maps protein clumping characteristics in neurodegenerative disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.